- Home
- Personal stories
Personal stories
Measuring what matters: The evolving role of impact measurement and management
Samatha Curtis from The Good Economy shares four recommendations for impact investors.
J&J Impact Ventures invests in Rology to expand access to critical, high-quality radiology diagnostics
By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.
Bridging the Gap: New J&J CareCommunity collaborations support 70,000 health workers across Latin America
By investing in health workers and local infrastructure, J&J CareCommunity is helping strengthen communities and expand access to care across Latin America.
Accelerating impact: The acquisition of CareAcademy by Activated Insights
With the acquisition, more health workers across the U.S. will be able to access a comprehensive learning platform to develop new skills.
Moving toward a more personalized approach to treating depression
The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.
J&J Impact Ventures invests in ThinkMD, increasing the availability and accuracy of clinical decision-making at the point of care
What if any healthcare worker—regardless of training, tenure or location—could be empowered with adaptive tools that enable them to conduct high-quality clinical assessments?
Is this the end of one-size-fits-all treatments for depression?
Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.
